Skip to content

Clinical Efficacy and Neuromodulation Mechanisms of Acupuncture Intervention in Cancer Pain Based on Dynamic Monitoring with Portable Wearable Multimodal Bioelectrical Signals

Clinical Efficacy and Neuromodulation Mechanisms of Acupuncture Intervention in Cancer Pain Based on Dynamic Monitoring with Portable Wearable Multimodal Bioelectrical Signals

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001552
Enrollment
Unknown
Registered
2025-08-11
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

Sham Acupuncture Group:Sham Acupuncture
Acupuncture Group:Acupuncture

Sponsors

Shenzhen Hospital (Fu Tian) of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed malignant tumor with pain caused by tumor invasion/progression or tumor treatment; 2.Aged 18 to 80 years with an expected survival of =3 months; 3.Moderate-to-severe pain defined as a Visual Analog Scale (VAS) score =4; 4.Conscious capable of understanding and communicating as required for the study and willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1 Pain related to oncological emergencies such as fractures visceral obstruction or perforation 2 Severe organ dysfunction or uncontrolled infections 3 Pregnant or lactating women 4 Patients with consciousness disorders mental disorders or communication difficulties unable to complete study questionnaires or scale assessments 5 Local infection inflammation or tumor infiltration at the acupuncture site 6 Coagulation dysfunction (INR > 1.5) or platelet count 7 Use of non-opioid analgesics implantable analgesic pumps nerve blockades or other invasive pain treatments in the past month 8 Patients using non-removable electronic devices or metal implants that may interfere with bioelectrical signal collection 9 Long-term use of immunosuppressants or high-dose corticosteroids

Design outcomes

Primary

MeasureTime frame
Minimal Important Difference (MID) in Visual Analogue Scale (VAS) Scores Before and After Treatment;

Secondary

MeasureTime frame
Brief Pain Inventory (BPI);Immediate Analgesic Effect;Electromyography;Karnofsky Performance Status Scale (KPS);Electrooculogram;Long-term Analgesic Effect;Indicator of Changes in Opioid Dosage;Electrodermal Activity;Electroencephalogram;

Countries

china

Contacts

Public ContactYufeng Xie

Shenzhen Hospital (Fu Tian) of Guangzhou University of Chinese Medicine

714732618@qq.com13760387089

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026